Clinical, epidemiological, and genomic evidence on mpox in mainland China, 2022–2025: a scoping review

Yanjie Peng, Yun Geng, Fan Yang, Ting Yang

Open source

DOI: 10.3389/fmicb.2026.1880110
Published: 2026-08-24
Container: Frontiers in Microbiology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmicb.2026.1880110,
  title = {Clinical, epidemiological, and genomic evidence on mpox in mainland China, 2022–2025: a scoping review},
  author = {Yanjie Peng and Yun Geng and Fan Yang and Ting Yang},
  year = {2026},
  journal = {Frontiers in Microbiology},
  doi = {10.3389/fmicb.2026.1880110},
  url = {https://doi.org/10.3389/fmicb.2026.1880110}
}

RIS

TY  - JOUR
TI  - Clinical, epidemiological, and genomic evidence on mpox in mainland China, 2022–2025: a scoping review
AU  - Yanjie Peng
AU  - Yun Geng
AU  - Fan Yang
AU  - Ting Yang
PY  - 2026
JO  - Frontiers in Microbiology
DO  - 10.3389/fmicb.2026.1880110
UR  - https://doi.org/10.3389/fmicb.2026.1880110
ER  -

APA

Peng, Y., Geng, Y., Yang, F., & Yang, T. (2026). Clinical, epidemiological, and genomic evidence on mpox in mainland China, 2022–2025: a scoping review. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2026.1880110

Source records

crossref · retrieved 2026-09-25T16:59:20.656Z